System for secure mobile healthcare selection

• US 8,326,648 B2
• Filed: 03/01/2011
• Issued: 12/04/2012
• Est. Priority Date: 09/10/2008
• Status: Active Grant

• Current Assignee: 23andme Incorporated (23andMe Holding Co.)
• Original Assignee: Expanse Networks, Inc.
• Inventors: Kenedy, Andrew Alexander, Eldering, Charles Anthony
• Primary Examiner(s): Najarian, Lena
• Assistant Examiner(s): WOODS, TERESA S
• Application Number:
  US13/037,834
• Publication Number:
  US 20110153355A1
• Time in Patent Office: 644 Days
• Field of Search: 370/462, 705/2, 705/3, 709/217
• US Class Current: 705/2
• CPC Class Codes: G06Q 20/3674 involving authentication
• CPC Class Codes: G06Q 20/382 insuring higher security of transaction
• CPC Class Codes: G06Q 30/02 Marketing; Price estimation or determination; Fundraising
• CPC Class Codes: G06Q 30/08 Auctions
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records

Abstract

A method, system and device for secure mobile healthcare selection are presented in which a user can, from a mobile device, authorize the comparison of pangenetic (genetic and epigenetic) data with data profiles corresponding to healthcare products, services and service providers to determine which are the most appropriate for a particular consumer. Data masking is used to maintain privacy of sensitive portions of the pangenetic data.

Claims

1. A networked system for enabling a mobile device and a computing system to determine a user'"'"'s likely success for disease treatment from a treatment provider by providing access to masked pangenetic data of said user by said computing system and enabling said user to accept or reject a treatment provider, comprising:

a) a receiving interface in said mobile device enabling receiving a request from said computing system requiring access to at least a portion of pangenetic data of said user stored on said mobile device;

b) an authorization interface actuated by said user granting access to said at least a portion the pangenetic data of said user by generating an authorization associated with at least one pre-approved data mask and creating masked pangenetic data associated with said user;

c) a transmission interface transmitting said masked pangenetic data associated with said user to said computing system; and

d) said computing system conducting a comparative assessment of said masked pangenetic data associated with said user with previously stored treatment provider related data on said computing system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment with correlated degrees of pangenetic data match of said user.

2. The networked system of claim 1, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

3. The networked system of claim 1 wherein the comparative assessment includes a recommendation for said user based on likely outcomes or success rates.

4. The networked system of claim 1 wherein said receiving interface, said authorization interface, and said transmission interface are contained within an application for said mobile device.

5. A computer based method for providing access to masked data of a user in a mobile environment to provide said user with data as to the likelihood of a useful therapeutic relationship being possible with respect to said user and a therapy provider, comprising:

a) transmitting a request from a second computer having therapy data stored therein to a mobile computer or processor, wherein the request includes requiring access to pangenetic data of said user stored on said mobile computer or processor;

b) receiving at least a portion of said user'"'"'s pangenetic information, wherein said at least a portion of said user'"'"'s pangenetic information is created from the application of at least one data mask; and

d) conducting a comparative assessment of said at least a portion of said user'"'"'s pangenetic data with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment having correlated degrees of pangenetic data match with said user.

6. The computer based method of claim 5, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

7. The computer based method of claim 5 wherein the data mask is authorized by the user.

8. The computer based method of claim 5 wherein the comparative assessment includes a recommendation for said user based on likely outcomes or success rates.

9. A program storage device readable by a machine and containing a set of instructions which, when read by the machine, causes execution of a computer based method for providing access to masked data of a user in a mobile environment to provide said user with data as to the likelihood of a useful therapeutic relationship being possible with respect to said user and a therapy provider, comprising:

a) transmitting a request from a second computer having therapy data stored therein to a mobile computer or processor, wherein the request includes a request for access to at least a portion of pangenetic data of said user stored on said mobile computer or processor;

b) processing an authorization initiated by said user associated with at least one pre-approved data mask authorized by said user to grant access to said at least a portion of pangenetic data of said user by said second computer and receiving said at least a portion of pangenetic data of said user; and

c) conducting a comparative assessment of said at least a portion of pangenetic data of said user with previously stored treatment provider related data on said second computer system to determine likely outcomes or success rates of said user with said treatment provider and providing said success rates to said user based on prior success rates of treatment of prior users of said treatment having correlated degrees of pangenetic data match with said user.

10. The computer based method of claim 9, wherein the pangenetic data are selected from the group consisting of single nucleotide polymorphisms, nucleotides, base pairs, nucleotide sequences, gene sequences, genomic sequences, gene mutations, epigenetic modifications, epigenetic sequence patterns, and pangenetic based disorders, traits and conditions.

11. The program storage device of claim 9 wherein the conducting a comparative assessment includes a recommendation for said user based on likely outcomes or success rates.